12. Top R&D Spenders of 2013

• #20. Merck KGaA

  2013 R&D spending: $1.638 billion (€1.183 billion)¹
  2012 R&D spending: $1.644 billion (€1.187 billion)¹
  % Change: -0.3%

• #19. Astellas Pharma

  2013 R&D spending: $1.771 billion (¥182.000 billion)
  2012 R&D spending: $1.846 billion (¥189.800 billion)
  % Change: -4.1%

• #18. Daiichi Sankyo

  2013 R&D spending: $1.777 billion (¥183.047 billion)
  2012 R&D spending: $1.796 billion (¥185.052 billion)
  % Change: -1.1%

• #17. Gilead Sciences

  2013 R&D spending: $2.120 billion
  2012 R&D spending: $1.760 billion
  % Change: 20.5%

• #16. Novo Nordisk

  2013 R&D spending: $2.178 billion (DKK 11.733 billion)
  2012 R&D spending: $2.023 billion (DKK 10.897 billion)
  % Change: 7.7% 

• #15. Celgene

  2013 R&D spending: $2.226 billion
  2012 R&D spending: $1.724 billion
  % Change: 29.1%

• #14. Bayer

  2013: R&D spending: $2.291 billion (€1.654 billion)²
  2012: R&D spending: $2.162 billion (€1.561 billion)²
  % Change: 6.0%

• #13. AbbVie³

  2013 R&D spending: $2.855 billion³
  2012 R&D spending: $2.778 billion³
  % Change: 2.8%

• #12. Takeda Pharmaceutical

  2013 R&D spending: $3.148 billion (¥324.292 billion)
  2012 R&D spending: $2.737 billion (¥281.885 billion)
  % Change: 15.0%

• #11. Bristol-Myers Squibb

  2013 R&D spending: $3.731 billion
  2012 R&D spending: $3.904 billion
  % Change: -4.4%
• • #10. Amgen

    2013 R&D spending: $3.929 billion
    2012 R&D spending: $3.296 billion
    % Change: 19.2%

  • #9. AstraZeneca

    2013 R&D spending: $4.821 billion
    2012 R&D spending: $5.243 billion⁴
    % Change: 13.7%

  • #8. Eli Lilly

    2013 R&D spending: $5.531 billion
    2012 R&D spending: $5.278 billion
    % Change: 4.8%

  • #7. GlaxoSmithKline

    2013 R&D spending: $6.518 billion (£3.923 billion)
    2012 R&D spending: $6.611 billion (£3.979 billion)⁵
    % Change: -1.4%

  • #6. Sanofi

    2013 R&D spending: $6.608 billion (€4.770 billion)
    2012 R&D spending: $6.818 billion (€4.922 billion)
    % Change: -3.1%

  • #5. Pfizer

    2013 R&D spending: $6.678 billion
    2012 R&D spending: $7.482 billion⁶
    % Change: -10.7%

  • #4. Merck & Co.

    2013 R&D spending: $7.503 billion
    2012 R&D spending: $8.168 billion
    % Change: -8.1%

  • #3. Johnson & Johnson

    2013 R&D spending: $8.183 billion
    2012 R&D spending: $7.665 billion
    % Change: 6.8%

  • #2. Novartis

    2013 R&D spending: $9.852 billion
    2012 R&D spending: $9.332 billion
    % Change: 5.6%

  • #1. Roche

    2013 R&D spending: $9.910 billion (CHF 8.700 billion)
    2012 R&D spending: $9.654 billion (CHF 8.475 billion)
    % Change: 2.7%